...with product discovery and development out there," said Stoffels, who was CEO of virology company Tibotec-Virco...

...platform-based acquisitions, one of antibody company Centocor Inc. in 1999 and another of antiviral company Tibotec-Virco...

...S.A. ; and Dirk Van Broekhoven as general counsel, formerly head of law group of Tibotec-Virco...

...and CAT. Other deals include $100 million in a private placement for infectious disease play Tibotec-Virco...

...Business: Neurological Hired: Christophe Bourrilly as VP of finance, formerly director of corporate finance at Tibotec-Virco...

...Graham as CMO, formerly VP of clinical research and medical affairs at Johnson & Johnson’s Tibotec-Virco...

...announced acquisition of Tibotec-Virco for $320 million in cash and debt (see BioCentury, March 25). Tibotec-Virco...

...Schering AG take out Collateral Therapeutics on a big premium plus Johnson & Johnson acquire Tibotec-Virco...

...may be a different story." JNJ catches anti-viral fever Johnson & Johnson 's acquisition of Tibotec-Virco...
...Belgian biotech will get the capital necessary to continue its clinical and preclinical development programs. Tibotec-Virco's...
...the second quarter, while its TMC-114 protease inhibitor is in Phase IIa trials. In addition, Tibotec-Virco...